Importance of controlling drug-resistant Pseudomonas aeruginosa infection: experience from lung transplantation in a cystic fibrosis case

Intern Med. 2010;49(21):2353-8. doi: 10.2169/internalmedicine.49.3932. Epub 2010 Nov 1.

Abstract

Cystic fibrosis (CF) is rare in Japan. We encountered a CF case with drug-resistant Pseudomonas aeruginosa infection and successfully performed lung transplant from living related donors. A combination of beta-lactams and aminoglycosides for drug-resistant P. aeruginosa infection was administered before lung transplantation. Intravenous colistin was also used immediately before and after transplant surgery. Gram staining of respiratory specimens was performed every day after surgery and it was useful in monitoring infection status. Strict monitoring of infections by the Gram staining and culture of respiratory specimens is considered to be effective in preventing lower respiratory infection in lung transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aminoglycosides / therapeutic use
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / diagnosis*
  • Cystic Fibrosis / drug therapy
  • Drug Resistance, Bacterial
  • Humans
  • Lung Transplantation* / adverse effects
  • Male
  • Pseudomonas Infections / diagnosis*
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / etiology
  • Pseudomonas aeruginosa / isolation & purification*
  • Young Adult
  • beta-Lactam Resistance*
  • beta-Lactams / therapeutic use

Substances

  • Aminoglycosides
  • beta-Lactams